55 East Monroe Street
Suite 3300
Chicago, Illinois 60603-5792

Mylan to Pay $57 Million to Settle Drug Overpricing Claims

February 28, 2012
Bloomberg

Mylan Inc. (MYL), the generic-drug company, agreed to pay $57 million to settle claims it caused the U.S. and California to overpay for drugs.

The settlement, filed yesterday in federal court in Boston, came in cases filed by Ven-A-Care of the Florida Keys Inc., a specialty pharmacy. California will get $26.3 million, the U.S. will get $22.2 million, and Ven-A-Care and its attorneys will get $8.5 million, court records show. To read the complete article click here.

Attorneys at law

 

resources

False claims act basics

Newsroom

Our successes

Our website uses cookies to improve your experience. By continuing to use this website, you are agreeing to our Cookie Policy.